期刊文献+

反转录-聚合酶链式反应检测促血管生成素-1和促血管生成素-2及Tie-2受体的mRNA在血管瘤组织中的表达及其意义

Expression of Ang-1, Ang-2 and Tie-2 receptor mRNAs and their implications in hemangioma by RT-PCR
原文传递
导出
摘要 目的研究血管瘤组织中促血管生成素-1(Ang-1)、促血管生成素-2(Ang-2)及Tie-2受体的mRNA表达水平,探讨其在血管瘤血管生成中的作用与意义。方法用反转录-聚合酶链式反应(RT—PCR)的方法分别检测30例血管瘤组织(增生期血管瘤17例,消退期血管瘤13例)以及10例小儿正常皮肤组织中Ang-1mRNA、Ang-2mRNA及Tie-2mRNA的表达水平。用免疫组织化学方法检测血管瘤组织Ki-67蛋白的表达。结果增生期血管瘤组织中Ang-2mRNA及Tie-2mRNA表达水平高于消退期血管瘤组织(P〈0.01)。血管瘤组织中Ang-1mRNA表达为阴性。结论Ang—Tie-2体系表达失衡在血管瘤的发生发展过程中可能起重要的作用。 Objective To detect the expression level of Ang-1, Ang -2 and Tie-2 receptor mRNAs in the hemangioma tissuses and to explore the effects of Ang-1, Ang-2, and Tie-2 receptor on the anglo- genesis in the hemangioma. Methods By use of serniquantinative reverse transcription polymerase chain reaction, we detected the expression level of Ang-1 mRNA, Ang-2 mRNA and Tie-2 mRNA in 30 cases of hemangioma (17 specimens of proliferating hemangioma, and 13 involuting hemangioma )together with 10 cases of normal skin as control, and the expression level of Ki-67 protein was also detected by an immunohistochemiea method. Results The expression of Ang-2 mRNA and Tie-2 mRNA in the proliferating hemangiomas was higher than that in involuting hemangiomas (P〈0.01) . The expression of Ang-1 mRNA in hemangiomas was negative. Conclusion The unbalance of Ang-Tie-2 system is probably important for the pathogenesis and development in hemangiomas.
出处 《中华医学美学美容杂志》 2009年第1期49-52,共4页 Chinese Journal of Medical Aesthetics and Cosmetology
基金 福建省教育厅科研基金资助项目(编号:JA05266)
关键词 血管瘤 促血管生成素 TIE-2受体 细胞增殖相关蛋白Ki-67 Hemangiornas Angiopoietin Tie-2 receptor Cell proliferation associated protein Ki-67
  • 相关文献

参考文献14

  • 1Dadras SS, North PE, Bertoncini J, et al. Infantile hemangiomas are arrested in an early developmental vascular differentiation state. J ModPathol, 2004,17(9):1068-1079.
  • 2Jang YC, Isik FF, Gibran NS. Nerve distribution in hemangiomas depends on the proliferative state of the mierovasculature. J Surg Res, 2000,93 (1):144-148.
  • 3Mulliken JB, Zetter BR, Folkman J. In vitro characteristics of endothelium from hemangiomas and vascular malformations. Surgery, 1982,92(2) ;348-353.
  • 4Takahashi K, Mulliken JB, Kozakewich HP, et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest, 1994,93(6):2357-2364.
  • 5杜彬,周序珑.血管生成素的特点及其对血管生成的调节作用[J].中国病理生理杂志,2003,19(2):275-278. 被引量:40
  • 6Fiedler U, Scharpfenecker M, Koidl S, et al. The Tie-2 ligand angiopoietin-2 is stored in and rapidly released upon stimulation from endothelial cell Weibel-Palade bodies. Blood, 2004 , 103(11) :4150-4156.
  • 7Hegen A, Koidl K, Weindel X, et al. Expression of angiopoietin 2 in endothelial cells is controlled by positive and negative regulatory promoter elements. Arterioscler Thromb Vasc Biol, 2004, 24(10): 1803-1809.
  • 8李红,张端莲,陕声国,余瑛,熊彦娥,尹芳,余方.血管瘤组织中Bcl-2的表达及其意义[J].武汉大学学报(医学版),2005,26(2):217-219. 被引量:3
  • 9Reynolds LE, Hodivala-Dilke KM. Primary mouse endothelial cell culture for assays of angiogenesis. Methods Mol Med, 2006,120(3):503-509.
  • 10Roguin A, Levy AP. Angiogenesis: an update. Pediatr Endo crinol Rev, 2005, 2(3) :391-398.

二级参考文献39

  • 1[1]Davis S, Aldrich TH, Jones PF, et al. Isolation of angiopoietin-1, a ligand for the tie2 receptor by secretion-trap expression cloning[J]. Cell, 1996, 87(7):1161-1169.
  • 2[2]Procopio WN, Paul IP, Lee WMF, et al. Angiopoietin-1 and -2 coiled coil domains mediate distinct homo-oligomerization patterns, but fibrinogen-like domains mediate ligand activity[J]. J Biol Chem, 1999,274(42): 30196-30201.
  • 3[3]Huang YQ, Li JJ, Karpatkin S. Identification of a family of alternatively spliced mRNA species of angiopoietin-1[J]. Blood, 2000,95(6): 1993-1999.
  • 4[4]Suri C, Jones PF, Patan S, et al. Requisite role of angiopoietin-1, a ligand for the tie2 receptor, during embryonic angiogenesis[J]. Cell, 1996, 87(7):1171-1180.
  • 5[5]Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for tie2 that disrupt in vivo angiogenesis[J]. Science, 1997, 277(5322):55-60.
  • 6[6]Nishimura M, Miki T, Yashima R, et al. Angiopoietin-3, a novel member of the angiopoietin family[J]. FEBS, 1999,448(3):254-256.
  • 7[7]Valenzuela DM, Griffiths JA, Rojas J, et al. Angiopoietin-3 and 4: diverging gene counterparts in mice and humans[J]. Proc Natl Acad Sci USA, 1999,96(5):1904-1909.
  • 8[8]Suri C, McClain J, Thurston G, et al. Increased vascularization in mice overexpressing angiopoietin-1[J]. Science, 1998,282(5388):468-471.
  • 9[9]Risau W. Mechanisms of angiogenesis[J]. Nature, 1997, 386(6626):671-674.
  • 10[10]Carmellet P, Ferrelra V, Breler B, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele[J]. Nature, 1996,380(6573):435-439.

共引文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部